SGP SpyGlass Pharma, Inc.: institutional ownership and insider trading

57 funds reported holding $581M of SpyGlass Pharma, Inc. in their latest 13F filings; in Q2 2026 funds net bought $17.1M, with 22 new positions and 5 funds selling out; over the last 12 months insiders bought $216M and sold $0 on the open market.

SGP revenue and earnings

Famous investors holding SGP

Largest institutional holders of SGP

  1. RA CAPITAL MANAGEMENT, L.P. — $179M
  2. NEA Management Company, LLC — $165M
  3. Sands Capital Alternatives, LLC — $55.7M
  4. Samsara BioCapital, LLC — $47.0M
  5. BlackRock, Inc. (BLK) — $15.8M
  6. PRICE T ROWE ASSOCIATES INC /MD/ — $15.0M
  7. Vestal Point Capital, LP — $14.9M
  8. JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) — $13.6M
  9. DEERFIELD MANAGEMENT COMPANY, L.P. — $12.2M
  10. MILLENNIUM MANAGEMENT LLC — $11.3M

Recent SGP insider trades

5%+ owners

Who owns the most SGP stock?

The largest institutional holders of SpyGlass Pharma, Inc. in the latest 13F filings are RA CAPITAL MANAGEMENT, L.P. ($179M), NEA Management Company, LLC ($165M), Sands Capital Alternatives, LLC ($55.7M).

Are insiders buying or selling SGP?

Over the last 12 months insiders bought $216M and sold $0 of SpyGlass Pharma, Inc. stock on the open market (SEC Form 4).

Which famous investors own SGP?

Izzy Englander.

Which ETFs hold SGP?

1 ETFs and mutual funds hold it among their top 100 positions, including BBC.

All SGP 13F holders · All SGP insider trades